Cover Image

Secretory Endometrial Adenocarcinoma in a Tamoxifen User With Breast Cancer After Menopause

Saved in:

Bibliographic Details
Main Authors:	Chia-Jen Wu (Author), Yi-Jen Peng (Author), Mu-Hsien Yu (Author), Chi-Huang Chen (Author)
Format:	Book
Published:	Elsevier, 2007-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Endometrial thickness in tamoxifen-treated women
by: Yiu-Tai Li, et al.
Published: (2023)

Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
by: I O Mamikonyan, et al.
Published: (2015)

A Reconsideration Of Tamoxifen Use for Breast Cancer
by: Peng-Hui Wang, et al.
Published: (2007)

Factors related to the experience of menopausal symptoms in women prescribed tamoxifen
by: Zoe Moon, et al.
Published: (2017)

Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020)

Evaluation of endometrial thickness in breast cancer patients with tamoxifen treatment - Difference between 2-dimensional ultrasonography and elastosonography
by: Hyun Been Jo, et al.
Published: (2023)

Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
by: Eva Dreisler
Published: (2022)

In Vitro and In Vivo Effects of Xanthorrhizol on Human Breast Cancer MCF-7 Cells Treated With Tamoxifen
by: Nattanant Noomhorm, et al.
Published: (2014)

Plexiform tumorlet in a woman with postmenopausal endometrioid endometrial carcinoma taking tamoxifen for breast cancer: A case report
by: Nektarios Koufopoulos, et al.
Published: (2022)

Features of ovarian steroidogenesis and endometrial hypertrophy during adjuvant therapy with tamoxifen in premenopausal patients with hormone-dependent breast cancer
by: A. Yu. Goryainova, et al.
Published: (2023)

Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact
by: Rafael Vargas-Castro, et al.
Published: (2023)

Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review
by: Wei-Ting Chao, et al.
Published: (2018)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
by: Jingwei Yao, et al.
Published: (2020)

Therapy of pathology secretory disease of the breast
by: G. Kh. Khanafiev, et al.
Published: (2016)

The benefits and costs of tamoxifen for breast cancer prevention
by: Simon D. Eckermann, et al.
Published: (2003)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019)

The use of tamoxifen in the treatment and prevention of breast cancer
by: Magdalena Hołowczuk, et al.
Published: (2019)

Secretory carcinoma of breast: A diagnostic dilemma
by: Anju Shukla, et al.
Published: (2020)

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
by: João Paulo Bianchi Ximenez, et al.
Published: (2019)

Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user
by: William T. Jaegle, et al.
Published: (2017)

Tamoxifen treatment adherence assessment by women with breast cancer
by: Caroline Oliveira Rangel, et al.
Published: (2020)

Radiation-induced circumscribed superficial morphea after brachytherapy for endometrial adenocarcinoma
by: Apoorva Trivedi, BS, et al.
Published: (2017)

The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene
by: Wen-Ling Lee, et al.
Published: (2008)

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model
by: Angel Pulido-Capiz, et al.
Published: (2024)

Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase
by: Okulicz William C, et al.
Published: (2004)

Uterine Fibroid in Breast Cancer Patients receiving Tamoxifen Therapy
by: Rismawati Tambunan, et al.
Published: (2021)

RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
by: Shuang Liu, et al.
Published: (2019)

Amyopathic dermatomyositis associated with an endometrial adenocarcinoma
by: Giuseppe Famularo
Published: (2017)

Epidemiological Factors in Patients with Endometrial Adenocarcinoma
by: Luis Enrique Pompa Montes de Oca, et al.
Published: (2011)

Metabolic Syndrome: Menopausal Women and the Health Care Challenge
by: Hei-Jen Jou, et al.
Published: (2009)

Spontaneous pneumothorax after intensive chemotherapy in endometrial cancer: A rare complication
by: Jen-Ruei Chen, et al.
Published: (2014)

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
by: Jaime D. Lewis, et al.
Published: (2014)

Interference of the tamoxifen dispensing system in the adherence to pharmacotherapy of women with breast cancer
by: Jamile Machado SANTOS, et al.
Published: (2023)

Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data
by: Bianca Kruger, et al.
Published: (2024)

Synergistic Effects of Lauryl Gallate and Tamoxifen on Human Breast Cancer Cell
by: Keihan GHATREH SAMANI, et al.
Published: (2020)

Effect of Allicin on Tamoxifen-sensitive MCF-7 Breast Cancer Cells
by: P Rahimi-Moghaddam, et al.
Published: (2015)

Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis
by: Tsung-Hsuan Lai, et al.
Published: (2018)

Endometrial Adenocarcinoma and Mucocele of the Appendix: An Unusual Coexistence
by: Ioannis Kalogiannidis, et al.
Published: (2013)

Endometrial adenocarcinoma initially mistaken as urinary incontinence
by: Chin-Ru Ker, et al.
Published: (2020)

Violaceous nodules in a patient with endometrial adenocarcinoma
by: Michelle A. McNally, RN, BSN, et al.
Published: (2021)